| CTRI Number |
CTRI/2019/06/019745 [Registered on: 18/06/2019] Trial Registered Prospectively |
| Last Modified On: |
17/06/2019 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Use of swashahara mahakashaya avleha in childhood bronchial asthma |
|
Scientific Title of Study
|
A Comparative Study to Evaluate the Efficacy of Shwasahara Mahakashaya Avleha w.r.to Shwasahara Mahakashaya choorna in Tamaka Shwasa w.s.r to Childhood Bronchial Asthma–An open ended, double armed, Randomized, Controlled Clinical Trial. |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
jitendra kumar acharya |
| Designation |
PG Scholar |
| Affiliation |
All India Institute of Ayurveda New Delhi |
| Address |
OPD 208, Hospital block, All India Institute of Ayurveda, Gautampuri,
Sarita Vihar All India Institute of Ayurveda, Gautampuri, Sarita Vihar
South West
DELHI
110076
India
South West DELHI 110076 India |
| Phone |
8368150104 |
| Fax |
|
| Email |
jitu.acharya91@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Rajagopala Shrikrishna |
| Designation |
Associate Professor |
| Affiliation |
All India Institute of Ayurveda |
| Address |
Room no. 403, 4th floor Academic block, All India Institute of
Ayurveda, Gautampuri, Sarita Vihar All India Institute of Ayurveda,
Gautampuri, Sarita Vihar
South West
DELHI
110076
India
South West DELHI 110076 India |
| Phone |
7600902564 |
| Fax |
|
| Email |
srajagopala@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Rajagopala Shrikrishna |
| Designation |
Associate Professor |
| Affiliation |
All India Institute of Ayurveda |
| Address |
Room no. 403, 4th floor Academic block, All India Institute of
Ayurveda, Gautampuri, Sarita Vihar All India Institute of Ayurveda,
Gautampuri, Sarita Vihar
South West
DELHI
110076
India
South West DELHI 110076 India |
| Phone |
7600902564 |
| Fax |
|
| Email |
srajagopala@gmail.com |
|
|
Source of Monetary or Material Support
|
| All india institute of Ayurveda |
| All india institute of Ayurveda,gautampuri,sarita vihar,nearmohan estate metro station,New Delhi 110076 |
|
|
Primary Sponsor
|
| Name |
All India Institute of Ayurveda |
| Address |
Saritavihar, Gautampuri New Delhi 110076 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| dr Rajagopala Srikrishna |
All india institute of ayurveda |
All india institute of ayurveda,gautampuri,sarita vihar,new delhi 110076 South West DELHI |
7600902564
srajagopala@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: J454||Moderate persistent asthma, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Shwasahara mahakashaya avleha |
Age in years Drug doses in
3 doses
5-7 6gm
8-10 9gm
11-13 12gm
14-15 15gm
ORALLY |
| Comparator Agent |
shwashahara mahakashaya choorna |
Age in year Drug dose in 2 divided doses
5-7 4gm
8-10 6gm
11-13 8gm
14-15 10gm
ROUTE-ORALLY |
|
|
Inclusion Criteria
|
| Age From |
5.00 Year(s) |
| Age To |
15.00 Year(s) |
| Gender |
Both |
| Details |
1) Individuals of either gender between age group of 5 to 15 years.
2) Diagnosed cases of Tamaka Shwasa –bronchial asthma with at least 3 episodes of asthma symptoms (cough, breathlessness) during the previous year.
3) Severity as mild to moderate stable bronchial asthma (Tamaka Shwasa) as per W.H.O GINA Guidelines.
4) Patient on other drug therapy will be included only after completion of the washout period of 3 weeks.
5) Parents giving consent to participate in study.
|
|
| ExclusionCriteria |
| Details |
1. Individuals below 5 years and above 15 years of age.
2. Sever case like status asthmaticus.
3. Evidence of active concomitants pulmonary disease other than asthma.
4. Evidence of requirement of intubation for asthma, or had been hospitalized for asthma within 1 month before. Had unresolved sinus disease or an unresolved upper or lower respiratory tract infection within 3 weeks. 5. More than 4 short courses of oral corticosteroids within the year preceding the screening visit or any oral corticosteroids in the preceding 4 weeks.
6. Concomitant severe decompensated systemic disease (cardiovascular, renal, hepatic, endocrine, haematological, neurological, immunological).
7. Patient/Parents not willing to participate in the study.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
1. Improvement in classical sign and symptoms of Tamaka Shwasa.
2.Decrease in frequency, duration and severity of attacks. |
0 day,15th day,30th day,45th day60th day |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1-Asthma control questionaire
2-GINA asthma guidelines
3-Ayurvedic parameters like Dasavidha parikshya,Astasthana parikshya
4-pulmonary function test and peak expiratory flow examination |
oday,60 day an one during follow up |
1-Asthma control questionaire
2-GINA asthma guidelines
3-Ayurvedic parameters like Dasavidha parikshya,Astasthana parikshya
4-pulmonary function test and peak expiratory flow examination |
oday,60 day an one during follow up |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
28/06/2019 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
outcomes will be published in peer journals for wider dissemination |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
. On the basis of their clinical manifestation. Tamaka Shwasa is as described in Ayurveda can be correlated with the disease bronchial asthma of modern medical science [1]. Bronchial asthma is characterized by chronic airway inflammation and increased airway.Bronchial asthma is characterized by chronic airway inflammation and increased airway responsiveness resulting in symptoms of wheeze, cough, chest tightness and dyspnoea. It is also functionally characterized by the air flow limitations which usually reverse spontaneously or with treatments. The prevalence of bronchial asthma has increased continuously since the 1970 and now effects 4-7% of the people worldwide[2]. There has been increase in the prevalence, and a similar trend is observed in India. Asthma prevalence rate in some states of India like Karnataka, Gujarat, Hariyana, Uttar Pradesh, Madhya Pradesh are above the national level[3]. The disease is more predominant in children and aged population. At the age of 6-7 years the prevalence ranges from 4%-32% apart from being the leading cause of hospitalization for children, it is one of the most important chronic condition causing elementary school absenteeism[4,5]. There is limited information on the various modalities of Ayurvedic management on Tamaka Shwasa i.e. Bronchial Asthma especially in children. The treatment principles of Tamaka Shwasa as described in our classical texts includes Shodhana, Shamana, herbal and herbominerals compound. In Charaka Samhita, It contributes several modalities of the treatment for Shwasa roga (asthma). Among all modalities of treatment, polyherbal combinations are said to be well-accepted, safe and effective in asthma. Maharsi Charaka described 10 drugs in Shwasahara Mahakashaya in sutra Sthana [6]. Acharya Charaka has summarized 500 kashayas in 50 Maha kashayas. The Maha kashayas are described with their characteristics. For example-the Maha kashayas which contains jeevaka, jeevanti etc. is termed as jeevaniya mahakashaya. Again these 50 Mahakashaya having classified in 10 groups. The sub classification has been done according to the similarities of name of Mahakashaya. Some group are classified on the basis of its action i.e Mahakashaya useful for panchakarma are grouped into subtypes like Snehopaga, Swedopaga,Vamanopaga etc. Among these, Shwasahara Mahakashaya also contains 10 drugs and is used to treat the condition of Pranavaha Srotas like Tamaka Swasa. The Shwasahara Mahakashaya contains 10 drugs such as – Shati, Puskarmoola, Amalavetas, Ela, Hingu, Agaru, Surasa, Tamalaki, Jeevanti and Chanda.OBJECTIVES OF THE RESEARCH PROJECT: The present research trial has been undertaken with the following objectives. PRIMARY OBJECTIVES:  To assess the efficacy of Shwasahara Mahakashaya in childhood bronchial asthma SECONDARY OBJECTIVE: -  To assess the improvement in quality of life of children and parents. METHODOLOGY: Patients will be randomly selected from OPD of age group 5-15 years. The children coming under the inclusion criteria of the study and their parents will be counselled and informed about the treatment plan. Those who are willing to undergo the therapy and ready to submit informed consent shall be recruited in the proposed clinical study. The selected subjects will be randomly divided into two groups with the help of computer generated randomization table. CLINICAL STUDY: | Study type | Interventional, Comparative, Superiority | | Purpose | Treatment | | Timing | Prospective | | End Point | Efficacy | | No. Of groups | Two groups | | Sample size | 60(30 in each group) | SETTING - Clinical study will be conducted in the department of Kaumarabhritya, All India Institute of Ayurveda, New Delhi. SIZE AND SAMPLE CALCULATION- As per the study of Neha R. Patel et.al [9], the proven efficacy of Shwasahara Mahakashaya choorna is 54% and 70% is expected in present study with the level of significance in 95% and power of 80%.the sample size is calculated on this base by using the following formula. Formula for 2 groups n =2 (Zα+Zβ)2/ (p0-p1)2 x pq Average sample size will be 144. |